J
Juni Palmgren
Researcher at Karolinska Institutet
Publications - 71
Citations - 9391
Juni Palmgren is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 35, co-authored 71 publications receiving 9042 citations. Previous affiliations of Juni Palmgren include University of Helsinki & SERC Reliability Corporation.
Papers
More filters
Journal ArticleDOI
Radical prostatectomy versus watchful waiting in early prostate cancer.
Anna Bill-Axelson,Anna Bill-Axelson,Lars Holmberg,Mirja Ruutu,Hans Garmo,Jennifer R. Stark,Jennifer R. Stark,Christer Busch,Stig Nordling,Michael Häggman,Swen-Olof Andersson,Stefan Bratell,Anders Spångberg,Juni Palmgren,Gunnar Steineck,Hans-Olov Adami,Hans-Olov Adami,Jan-Erik Johansson +17 more
TL;DR: Radical prostatectomy was associated with a reduction in the rate of death from prostate cancer, and men with extracapsular tumor growth may benefit from adjuvant local or systemic treatment.
Journal ArticleDOI
α-Tocopherol and β-Carotene Supplements and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of Base-line Characteristics and Study Compliance
Demetrius Albanes,Olli P. Heinonen,Philip R. Taylor,Jarmo Virtamo,Brenda K. Edwards,Matti Rautalahti,Anne M. Hartman,Juni Palmgren,Laurence S. Freedman,Jaason Haapakoski,Michael J. Barrett,Pirjo Pietinen,Nea Malila,Tala E,Kari Liippo,Eija Riitta Salomaa,Joseph A. Tangrea,Lyly Teppo,Frederic B. Askin,Eero Taskinen,Yener S. Erozan,Peter Greenwald,Jussi K. Huttunen +22 more
TL;DR: In this article, the effects of alpha-tocopherol and beta-carotene supplementation on the incidence of lung cancer across subgroups of participants in the ATBC Study defined by base-line characteristics (e.g., age, number of cigarettes smoked, dietary or serum vitamin status, and alcohol consumption), by study compliance, and in relation to clinical factors, such as disease stage and histologic type.
Journal ArticleDOI
Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
Anna Bill-Axelson,Lars Holmberg,Hans Garmo,Jennifer R. Rider,Kimmo Taari,Christer Busch,Stig Nordling,Michael Häggman,Swen-Olof Andersson,Anders Spångberg,Ove Andrén,Juni Palmgren,Gunnar Steineck,Hans-Olov Adami,Jan-Erik Johansson +14 more
TL;DR: Extended follow-up confirmed a substantial reduction in mortality after radical prostatectomy; the number needed to treat to prevent one death continued to decrease when the treatment was modified according to age at diagnosis and tumor risk.
Journal ArticleDOI
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer
Lars Holmberg,Anna Bill-Axelson,Fred Helgesen,Jaakko O. Salo,Per Folmerz,Michael Häggman,Swen-Olof Andersson,Anders Spångberg,Christer Busch,Steg Nordling,Juni Palmgren,Hans-Olov Adami,Jan-Erik Johansson,Bo Johan Norlén +13 more
TL;DR: In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival.
Journal ArticleDOI
Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial
Anna Bill-Axelson,Lars Holmberg,Frej Filén,Mirja Ruutu,Hans Garmo,Christer Busch,Stig Nordling,Michael Häggman,Swen-Olof Andersson,Stefan Bratell,Anders Spångberg,Juni Palmgren,Hans-Olov Adami,Jan-Erik Johansson +13 more
TL;DR: Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.